These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17330607)

  • 21. Effect of vaginal pH on the efficacy of vaginal misoprostol for induction of midtrimester abortion.
    Abd-El-Maeboud KH; Ghazy AA; Nadeem AA; Al-Sharaky A; Khalil AE
    J Obstet Gynaecol Res; 2008 Feb; 34(1):78-84. PubMed ID: 18226134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions.
    Aldrich T; Winikoff B
    BJOG; 2007 May; 114(5):555-62. PubMed ID: 17439563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Misoprostol: Why Gymiso?].
    Ulmann A
    Gynecol Obstet Fertil; 2006 Oct; 34(10):883-4. PubMed ID: 16997606
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcomes for subsequent pregnancy in women who have undergone misoprostol mid-trimester termination of pregnancy.
    Mirmilstein V; Rowlands S; King JF
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):195-7. PubMed ID: 19432610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Misoprostol: first-line therapy for incomplete miscarriage in the developing world.
    Gemzell-Danielsson K; Fiala C; Weeks A
    BJOG; 2007 Nov; 114(11):1337-9. PubMed ID: 17949375
    [No Abstract]   [Full Text] [Related]  

  • 29. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
    Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
    BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is abortion a religious issue? 3. The irrelevance of religion in the abortion debate.
    Newton L
    Hastings Cent Rep; 1978 Aug; 8(4):16-7. PubMed ID: 689866
    [No Abstract]   [Full Text] [Related]  

  • 33. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation.
    Prasad S; Kumar A; Divya A
    Fertil Steril; 2009 Jan; 91(1):28-31. PubMed ID: 18295212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serious adverse events associated with the use of misoprostol alone for cervical preparation prior to early second trimester abortions (12-16 weeks).
    Nucatola D; Saulsberry V; Gatter M; Roth N
    Contraception; 2009 Feb; 79(2):158. PubMed ID: 19135576
    [No Abstract]   [Full Text] [Related]  

  • 36. Misoprostol in obstetrics.
    Majoko F
    BJOG; 2005 Dec; 112(12):1666. PubMed ID: 16305575
    [No Abstract]   [Full Text] [Related]  

  • 37. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy termination using vaginal misoprostol in women with more than one caesarean section.
    Daponte A; Nzewenga G; Dimopoulos KD; Guidozzi F
    J Obstet Gynaecol; 2007 Aug; 27(6):597-600. PubMed ID: 17896259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
    Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Good results of early medicinal pregnancy termination in a general practice on Curaçao].
    Boersma AA; Meyboom-de Jong B
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):504-8. PubMed ID: 18389885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.